PortalPublikationenTacrolimus or cyclosporine for immunosuppression after cardi...

Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation_ which treatment reveals more side effects during long-term follow-up?

Standard

Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation_ which treatment reveals more side effects during long-term follow-up? / Groetzner, J; Meiser, B M; Schirmer, J; Koglin, J; vScheidt, W; Klauss, V; Cremer, P; Reichenspurner, H; Reichart, B.

in: TRANSPL P, Jahrgang 33, Nr. 1-2, 27.03.2001, S. 1461-1464.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Groetzner, J, Meiser, BM, Schirmer, J, Koglin, J, vScheidt, W, Klauss, V, Cremer, P, Reichenspurner, H & Reichart, B 2001, 'Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation_ which treatment reveals more side effects during long-term follow-up?', TRANSPL P, Jg. 33, Nr. 1-2, S. 1461-1464. https://doi.org/10.1016/s0041-1345(01)01906-6

APA

Groetzner, J., Meiser, B. M., Schirmer, J., Koglin, J., vScheidt, W., Klauss, V., Cremer, P., Reichenspurner, H., & Reichart, B. (2001). Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation_ which treatment reveals more side effects during long-term follow-up? TRANSPL P, 33(1-2), 1461-1464. https://doi.org/10.1016/s0041-1345(01)01906-6

Vancouver

Groetzner J, Meiser BM, Schirmer J, Koglin J, vScheidt W, Klauss V et al. Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation_ which treatment reveals more side effects during long-term follow-up? TRANSPL P. 2001 Mär 27;33(1-2):1461-1464. https://doi.org/10.1016/s0041-1345(01)01906-6

Bibtex

@article{02bb26f1441744cb864e103073742517,
title = "Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation_ which treatment reveals more side effects during long-term follow-up?",
keywords = "Adult, Creatinine/blood, Cyclosporine/adverse effects, Diabetes Mellitus/chemically induced, Female, Follow-Up Studies, Graft Rejection/epidemiology, Heart Transplantation/immunology, Humans, Hyperlipidemias/chemically induced, Hypertension/chemically induced, Immunosuppressive Agents/adverse effects, Incidence, Kidney Diseases/chemically induced, Male, Middle Aged, Prospective Studies, Tacrolimus/adverse effects",
author = "J Groetzner and Meiser, {B M} and J Schirmer and J Koglin and W vScheidt and V Klauss and P Cremer and H Reichenspurner and B Reichart",
year = "2001",
month = mar,
day = "27",
doi = "10.1016/s0041-1345(01)01906-6",
language = "English",
volume = "33",
pages = "1461--1464",
journal = "TRANSPL P",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "1-2",

}

RIS

TY - JOUR

T1 - Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation_ which treatment reveals more side effects during long-term follow-up?

AU - Groetzner, J

AU - Meiser, B M

AU - Schirmer, J

AU - Koglin, J

AU - vScheidt, W

AU - Klauss, V

AU - Cremer, P

AU - Reichenspurner, H

AU - Reichart, B

PY - 2001/3/27

Y1 - 2001/3/27

KW - Adult

KW - Creatinine/blood

KW - Cyclosporine/adverse effects

KW - Diabetes Mellitus/chemically induced

KW - Female

KW - Follow-Up Studies

KW - Graft Rejection/epidemiology

KW - Heart Transplantation/immunology

KW - Humans

KW - Hyperlipidemias/chemically induced

KW - Hypertension/chemically induced

KW - Immunosuppressive Agents/adverse effects

KW - Incidence

KW - Kidney Diseases/chemically induced

KW - Male

KW - Middle Aged

KW - Prospective Studies

KW - Tacrolimus/adverse effects

U2 - 10.1016/s0041-1345(01)01906-6

DO - 10.1016/s0041-1345(01)01906-6

M3 - SCORING: Journal article

C2 - 11267373

VL - 33

SP - 1461

EP - 1464

JO - TRANSPL P

JF - TRANSPL P

SN - 0041-1345

IS - 1-2

ER -